HHS Nominates 2 Acting Officials to Top FDA Drug and Biologics Posts
The Washington Post2d ago HHS Nominates Michael Davis, Karim Mikhail to Top FDA Drug, Biologics RolesUS names acting FDA drug, vaccine chiefs to permanent posts | ReutersFDA makes acting CDER, CBER chiefs permanent | pharmaphorumFDA gains 'continuity' as Mikhail, Davis named permanent CBER, CDER leaders | PharmaVoiceHHS Names Permanent Leaders of FDA Drug and Vaccine Centers, Setting the Direction for Future ReviewsFDA Fills Four Senior Roles, Including Top Officials for Drugs and Vaccines | MedPage TodayBioPharm International2d ago HHS Names Karim Mikhail as CBER Director, Michael Davis as CDER Director in Broader FDA Leadership Shake-Up | BioPharm InternationalHHS Announces Four Key FDA Leadership Selections Across CDER, CBER, CTP and AI - OncoDailyFour leadership appointments will help shape how the FDA handles medicines, vaccines, tobacco and artificial intelligence. Health Secretary Robert F. Kennedy Jr. named Karim Mikhail to lead the biologics center, which overseesFDA fills four senior roles, including top officials for drugs, vaccines and tobaccoTrump administration names permanent FDA division leadersWJW FOX 8 News Cleveland2d ago FDA fills four senior roles, including top officials for drugs, vaccines and tobacco | Fox 8 Cleveland WJW